The global general surgical devices market size is forecasted to grow to USD 1.97 billion by the end of 2029 from USD 1.21 billion in 2024. This market is predicted to witness a CAGR of 10.20% between 2024 to 2029.
The prevalence of chronic diseases such as cardiovascular diseases, cancer, respiratory diseases and diabetes has been growing rapidly in the last few years and have become global health concerns. Sedentary lifestyles, unhealthy diets, aging populations and genetic predispositions majorly contribute to the growing incidence of chronic diseases among people. People suffering from chronic diseases often require surgical interventions as part of their treatment or management and are likely to go through surgical procedures. Likewise, the growing prevalence of chronic diseases worldwide is fuelling the demand for general surgical devices and contributing to market growth.
The growing global aging population further contributes to the growth of the general surgical devices market. The number of people turning above 60 years is on the rise worldwide. As per the statistics published by World Health Organization (WHO), the population of 60 years and more is estimated to reach 2.1 billion by 2050. People who are aged are more susceptible to age-related diseases and conditions that require surgical treatment. Such patients undergo surgical procedures to alleviate symptoms, improve their quality of life and prolong their lifespan. The aging population is also more likely to experience degenerative musculoskeletal conditions such as osteoarthritis that require joint replacement surgeries. The growing number of surgical interventions in the aging population is propelling the demand for general surgical devices and this trend is likely to continue in the coming years and promote the market growth.
Technological advancements propel the general surgical devices market growth. Surgical technology has experienced several technological advancements in recent years such as minimally invasive procedures, robotic surgery and advanced imaging techniques. These technological advancements further resulted in the increased adoption of general surgical devices as they offer benefits such as reduced trauma, shorter recovery time, and improved patient outcomes. The growing healthcare expenditure supports the growth of the general surgical devices market. Healthcare expenditure by the governments of various countries and people has been growing gradually over the last several years and this has contributed to the improved healthcare infrastructure and access to surgical procedures and boosted the demand for general surgical devices. This trend is expected to propel in the coming years and fuel market growth.
The growing number of initiatives and reimbursement policies by governments that support surgical procedures and promote access to healthcare services, the rise in medical tourism, and strategic collaborations and partnerships of market participants with healthcare providers and research institutions to develop innovative surgical solutions and improve patient care accelerate the market growth. The rising awareness about the benefits of surgical interventions and patient education about the available treatment options, the growing number of surgical procedures, continuous advancements in materials science and manufacturing techniques, an increasing number of elective surgeries such as cosmetic procedures and joint replacements and rising emphasis of patient safety and infection control in surgical procedures further drive the general surgical devices market growth.
Stringent regulatory requirements and approval processes for general surgical devices and the high cost associated with the development, manufacturing, and maintenance of general surgical devices primarily hamper the market growth. Limited reimbursement policies or inadequate coverage for certain surgical procedures and devices and the shortage of skilled surgeons and healthcare professionals trained in the use of advanced surgical devices further hinder the growth of the global market. The availability of alternative treatment options, such as non-surgical interventions or alternative therapies and limited healthcare infrastructure in some countries are diluting the growth rate of the global general surgical devices market.
The burden on health systems by the COVID-19 pandemic has varied across countries and regions. As a result, the volumes of general surgery procedures and the sales of their associated devices have also varied globally. In the United States, the initial wave of the pandemic occurred in 2020, causing an almost 52% year-over-year drop in sales of laparoscopic access instruments, such as trocars and retractors, which are frequently used in general surgery. However, as elective surgeries resumed at the end of 2020 and were performed at 75% - 92% before COVID-19 rates, most surgical device companies began to recover lost revenue immediately. As a result, the overall decline in sales for 2020 was not as severe as initially expected. As the ongoing global deployment of COVID-19 vaccines continues and healthcare systems respond more aggressively to the demand for elective interventions, the market for general surgery devices is expected to grow in 2021. This increase in market value could continue until 2022, depending on global vaccine distribution and inoculation rates.
REPORT METRIC |
DETAILS |
Market Size Available |
2023 to 2029 |
Base Year |
2023 |
Forecast Period |
2024 to 2029 |
Segments Covered |
By Technology, End User, Type & Region |
Various Analyses Covered |
Global, Regional & Country Level Analysis, Segment-Level Analysis; DROC, PESTLE Analysis; Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview of Investment Opportunities |
Regions Covered |
North America, Europe, APAC, Latin America, Middle East & Africa |
Market Leaders Profiled |
Medtronic PLC, Stryker Corporation, Johnsons And Johnsons, Conmed Corporation, Alcon Laboratories Inc., Smith & Nephew PLC, Zimmer Holdings Inc., Boston Scientific Corporation, B. Braun Melsungen AG, KLS Martin Group |
Based on type, the forceps segment had a considerable share of the global market in 2023 and is expected to grow at a healthy CAGR during the forecast period. The broad range of applications of forceps, the growing number of surgical procedures, such as minimally invasive surgeries and robotic surgeries, technological advancements in forceps design such as ergonomic handles and improved materials and the rising geriatric population globally majorly drive the growth of the forceps segment.
The scissors segment is anticipated to witness a promising CAGR during the forecast period. The importance and widespread use of scissors in various surgical specialties, technological advancements in scissor design, such as sharper blades, ergonomic handles and specialized variations for specific surgical procedures, the rising number of surgical procedures and the growing adoption of minimally invasive procedures propel the growth of the scissors segment.
Based on technology, the electrosurgical equipment segment is expected to register the fastest CAGR during the forecast period owing to the rising demand for these devices among the growing number of minimally invasive surgical procedures. The advantages of electrosurgical equipment such as precise tissue cutting and coagulation, reduced blood loss, faster healing and minimal scarring are one of the major factors driving segmental growth. The growing volume of surgical procedures worldwide, continuous advancements in electrosurgical technology and rising popularity of minimally invasive surgeries further contribute to the segmental growth.
The wireless segment is anticipated to register a healthy CAGR during the forecast period owing to the enhanced mobility and flexibility of wireless surgical equipment, rising demand for minimally invasive surgical procedures and growing focus on patient comfort and safety.
Based on end-user, the hospital segment had the largest share of the global market in 2023 and the domination of the hospital segment in the global market is likely to continue throughout the forecast period. The growing volume of patients visiting hospitals for surgical procedures due to their comprehensive healthcare services and infrastructure majorly drives the growth of the hospital segment. The growing prevalence of chronic diseases, such as cardiovascular disorders, cancer and orthopedic conditions and growing initiatives and funding by governments to improve the hospital infrastructure development further boost the growth rate of the segment.
North America led the general surgical devices market worldwide in 2023 and the domination of the North American region in the global market is predicted to continue throughout the forecast period. Factors such as favorable reimbursement policies, technological advancements in surgical devices and the growing patient population suffering from chronic diseases in North America primarily drive the demand for general surgical devices and boost the North American general surgical devices market growth. The rising demand for minimally invasive surgeries, the presence of well-established healthcare infrastructure and the increasing geriatric population in the North American countries further contribute to the growth rate of the North American market. The U.S. had the leading share of the North American market in 2023 and is expected to grow at a prominent CAGR during the forecast period owing to the presence of advanced healthcare facilities and high healthcare expenditure.
Europe is another noteworthy regional market for general surgical devices and is anticipated to account for a substantial share of the global market during the forecast period. The growing aging population, increasing healthcare needs, rising number of initiatives from the European governments to enhance healthcare infrastructure and rising number of surgical procedures majorly boost the growth of the European general surgical devices market. The rising adoption of advanced surgical technologies, growing prevalence of chronic diseases and increasing emphasis on patient safety and quality of care further propel the European market growth. Germany led the market in Europe, followed by France in 2023.
APAC is the most lucrative regional market for general surgical devices worldwide and is expected to grow at the fastest CAGR during the forecast period. The presence of a large patient population, growing healthcare expenditure, rising medical tourism and improving healthcare infrastructure in the countries of the Asia-Pacific region primarily boost the APAC general surgical devices market growth. The growing adoption of advanced surgical techniques and expansion of the private healthcare sector in this region further drive regional market growth. China and India are expected to occupy the major share of the APAC market during the forecast period.
Latin America accounted for a considerable share of the global market in 2023 and is expected to grow at a healthy CAGR during the forecast period. The growth of the Latin American general surgical devices market is primarily driven by the rising demand for surgical procedures, the growing prevalence of chronic diseases and the rapid adoption of advanced surgical technologies. Brazil followed by Mexico dominated the market in Latin America in 2023.
The MEA market had a moderate share of the global market in 2023 and is projected to grow at a steady CAGR in the coming years. Factors such as the growing healthcare infrastructure, rising investments in healthcare facilities and an increasing number of initiatives from the governments of MEA countries to improve healthcare access drive the MEA general surgical devices market growth. The United Arab Emirates and Saudi Arabia are anticipated to play the leading role in the MEA market during the forecast period.
Companies that are playing a dominating role in the global general surgical devices market profiled in the report are Medtronic PLC, Stryker Corporation, Johnsons And Johnsons, Conmed Corporation, Alcon Laboratories Inc., Smith & Nephew PLC, Zimmer Holdings Inc., Boston Scientific Corporation, B. Braun Melsungen AG, KLS Martin Group, Olympus Corporation, Applied Medical Resources Corporation, Microline Surgicals, Inc., Karl Storz GmbH & Co. KG, Cook Medical Incorporated and Teleflex Incorporated.
By Type
By Technology
By End User
By Region
Frequently Asked Questions
The global general surgical devices market size was valued at USD 1.21 billion in 2024.
The North American region accounted for the major share of the global general surgical devices market in 2023.
Medtronic PLC, Stryker Corporation, Johnsons And Johnsons, Conmed Corporation, Alcon Laboratories Inc., Smith & Nephew PLC, Zimmer Holdings Inc., Boston Scientific Corporation, B. Braun Melsungen AG, KLS Martin Group, Olympus Corporation, Applied Medical Resources Corporation, Microline Surgicals, Inc., Karl Storz GmbH & Co. KG, Cook Medical Incorporated and Teleflex Incorporated are some of the notable companies in the global general surgical devices market.
Related Reports
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2500
Didn’t find what you’re looking for?
TALK TO OUR ANALYST TEAM
Need something within your budget?
NO WORRIES! WE GOT YOU COVERED!
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: [email protected]
Reports By Region